Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CALM-DR: Calcium Dobesilate in Mild to Moderate Non-proliferative Diabetic Retinopathy
NCT04283162Phase 4Unknown
- Sponsor
- Zhongda Hospital, Southeast University
- Start
- Mar 2020
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of calcium dobesilate in diabetic retinopathy (DR), sponsored by Zhongda Hospital, Southeast University. Status: unknown.
02
Drugs
calcium dobesilate
03
Conditions
diabetic retinopathy (DR)
Beyond the preview
Go deeper on NCT04283162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04283162.